Status : Published | Published On : Jan, 2024 | Report Code : VRSME9077 | Industry : Semiconductor & Electronics | Available Format :
![]() |
Page : 125 |
The Global Pharmaceuticals And Biotech Industry's Testing, Inspection, And Certification Market reached USD 13.5 billion in 2030, currently in 2023 the market is USD 6.8 billion with a projected CAGR of 5.6% from 2025 to 2030. These services improve manufacturing quality and compliance with global regulations. Inspection and testing are crucial for quality control, impacting costs, productivity, on-time delivery, and market share.
The pharmaceutical and biotech industry develops drugs and other products so that people and animals can live healthier lives, recover from injuries, and fight diseases. Moreover, globalization, urbanization, stringent safety regulations, increasing trade of counterfeit and pirated products, growth in networking and communication technology, favorable government initiatives, rules & regulations by the government has propelled the growth of the TIC market in the pharmaceuticals and biotech industry. Quality, assurance, and transparency are significant for manufacturers in the pharmaceuticals & biotech industry. Manufacturers of pharmaceutical products must strictly control the distribution of their products to ensure the correct dosage and minimize the risk of overdose or dependence on the patient., resulting in the growth of TIC services.
TIC services are used by pharmaceutical & biotech companies, diagnostic centers, medical devices, clinical research, and digital health applications in the healthcare sector to curb the spread of coronavirus. Pharmaceutical companies are producing medicines, remedies, and injections to battle against the coronavirus. Countries are spending huge amounts of money on R&D vaccines, increasing their budgets for the healthcare industry, and need to work closely with regulators and policymakers resulting in the growth of TIC services in the pharmaceuticals and biotech industry.
Based on sourcing type, the TIC market for the pharmaceuticals and biotech industry is categorized into in-house and outsourced. Among the two segments, the in-house segment contributes in holding the largest share during the forecast period 2025-2030. The in-house testing provides benefits of controlling the technology, skilled personnel, full-service laboratories, and testing and measurement equipment. Moreover, it can also help manufacturers in reducing in-house compliance costs and easily respond to global market demands. Therefore, the pharmaceuticals and biotech industry chose in-house services over outsourced services due to the criticality of applications.
Based on service type, the TIC market for the pharmaceuticals and biotech industry is segmented into testing, inspection, and certification. Testing dominates the TIC market in the pharmaceutical and biotech industry in 2020 due to diverse standards, mandatory regulations, rising adoption for improved safety, industrialization, and a need to provide credibility. Testing in the pharmaceutical industry should be on quality assurance, ingredient validation, and label reviews, microbiological testing, benchmarking analysis, and testing according to U.S. FDA and others.
Based on industry vertical, the TIC market for the pharmaceuticals and biotech industry is divided into extractable and leachable studies, environmental monitoring, biopharmaceutical, and biologics analysis, sterile compounding, pharmaceutical method development, and research, pharmaceutical X-ray diffraction, excipient raw materials, and container testing, material sciences testing, disinfection qualification, trace metal services, and others. There is a need to study the impact of extractable and leachable substances on the safety and drug product interaction and is significant in order to protect the patient and comply with regulations. Medications that need to be sterile include injectables, IV, intraocular, and compounding medications will allow pharmacists to make individual prescriptions for patients that require unique dosing, allergies, or rare diseases to prevent them from taking commercially available formulations.
Report Metric |
Details |
Historical Period |
2018 - 2023 |
Base Year Considered |
2024 |
Forecast Period |
2025 - 2030 |
Market Size in 2024 |
U.S.D. 6.8 Billion |
Revenue Forecast in 2030 |
U.S.D. 13.5 Billion |
Growth Rate |
5.6% |
Segments Covered in the Report |
By Sourcing Type, By Service Type, and By Industry Vertical |
Report Scope |
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling |
Regions Covered in the Report |
North America, Europe, Asia-Pacific, Middle East, and Rest of the World |
The TIC market for the pharmaceuticals and biotech industry is characterized by various industry trends like AI and machine learning in drug discovery, the evolution of cloud computing in providing innovation in pharmaceuticals, and molecular computers are developing the future of medicine, rising mergers & acquisitions by the market players.
During the forecast period, regulatory standards are expected to impact the pharmaceuticals and biotech industry. The market's growth, R&D investments, digital platform transformation, healthcare standards, and certification requirements are driving the demand for TIC services in this industry. Additionally, manufacturing companies are focusing on quality products to retain customers, while the increasing demand for connected devices and IoT is fueling the growth of the TIC market in pharmaceuticals and biotech.
Trade wars, growth fluctuations, massive investment in automation, increasing costs involved due to various standards and regulations globally, lack of testing facilities, and lack of skilled personnel are the challenges faced by the TIC market for the pharmaceuticals and the biotech industry. Furthermore, pharmaceutical products have a specified shelf life, the challenge in the supply chain, and storage conditions may restrict the growth of the pharmaceutical & biotech industry.
Technologies such as AI, robotics, drones, big data analytics, next-generation automation, and cloud and cybersecurity are the opportunities in the TIC market for the pharmaceuticals and the biotech industry.
Geographically, APAC is projected to have a high CAGR during the estimated period due to the rising investment in R&D, urbanization, huge manufacturing capabilities and exports, changes in lifestyle, and growing consumer awareness about the importance of certification. Moreover, the increasing dependence of European and American countries on Asia-Pacific companies for medical devices, PPE kits, pharmaceuticals, and other necessary equipment, will result in bolstering the growth of the TIC market in the pharmaceuticals & biotech industry. Nevertheless, the rising middle-class population will create growth in private consumption and bolstering demand for safety and product quality, resulting in providing opportunities in pharmaceutical and biotech testing.
The industry players are making technological changes to enhance their product portfolio, prioritizing their R&D, technological transformation, and providing a global market presence. Moreover, the industry players in the TIC market have started building strategies like mergers and acquisitions to generate new revenue channels.
Intertek pharmaceutical contract laboratory services, regulatory guidance and supply chain assurance brings quality and safety to life to support your unique pharmaceutical outsourcing requirements.
ALS has a variety of services and subject matter experts who can help fulfill the pharmaceutical and healthcare service needs.
Some of the key players operating in the TIC market in the mining industry: Intertek Group plc, Bureau Veritas, UL LLC, SGS SA, Eurofins Scientific, The British Standards Institution, ALS Limited, DEKRA SE, Applus+, and TUV SUD.
EverythingALS has introduced a platform aimed at advancing amyotrophic lateral sclerosis (ALS) research using artificial intelligence (AI) and machine learning with the ultimate goal of eradicating the disease and restoring lost motor function to those with ALS and other neurodegenerative disorders.
Eurofins Viracor Launches Ground-Breaking Test for Assessing Expansion and Persistence of CAR-T Therapy in Cancer Patients.
Intertek announced that IntertekMedical Notified Body AB (IMNB) was designated against MDR 2017/745 by the Swedish Competent Authority. This designation may help the company to better penetrate its service and solutions in the European region.
The TIC Market for Pharmaceuticals & Biotech Industry report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.
Segments Covered in the Report
Region Covered in the Report
Source: VynZ Research
Source: VynZ Research
1. Research Overview
1.1. The Report Offers
1.2. Market Coverage
1.2.1. By Sourcing Type
1.2.2. By Service Type
1.2.3. By Industry Vertical
1.2.4. By Region
1.3. Research Phases
1.4. Limitations
1.5. Market Methodology
1.5.1. Data Sources
1.5.1.1. Primary Research
1.5.1.2. Secondary Research
1.5.2. Methodology
1.5.2.1. Data Exploration
1.5.2.2. Forecast Parameters
1.5.2.3. Data Validation
1.5.2.4. Assumptions
1.5.3. Study Period & Data Reporting Unit
2. Executive Summary
3. Industry Overview
3.1. Industry Dynamics
3.1.1. Market Growth Drivers
3.1.2. Market Restraints
3.1.3. Key Market Trends
3.1.4. Major Opportunities
3.2. Industry Ecosystem
3.2.1. Porter’s Five Forces Analysis
3.2.2. Recent Development Analysis
3.2.3. Value Chain Analysis
3.3. Competitive Insight
3.3.1. Competitive Position of Industry Players
3.3.2. Market Attractive Analysis
3.3.3. Market Share Analysis
4. Global Market Estimate and Forecast
4.1. Global Market Overview
4.2. Global Market Estimate and Forecast to 2030
5. Market Segmentation Estimate and Forecast
5.1. By Sourcing Type
5.1.1. In-House
5.1.1.1. Market Definition
5.1.1.2. Market Estimation and Forecast to 2030
5.1.2. Outsourced
5.1.2.1. Market Definition
5.1.2.2. Market Estimation and Forecast to 2030
5.2. By Service Type
5.2.1. Testing
5.2.1.1. Market Definition
5.2.1.2. Market Estimation and Forecast to 2030
5.2.2. Inspection
5.2.2.1. Market Definition
5.2.2.2. Market Estimation and Forecast to 2030
5.2.3. Certification
5.2.3.1. Market Definition
5.2.3.2. Market Estimation and Forecast to 2030
5.3. By Industry Vertical
5.3.1. Extractable and Leachable Studies
5.3.1.1. Market Definition
5.3.1.2. Market Estimation and Forecast to 2030
5.3.2. Environmental Monitoring
5.3.2.1. Market Definition
5.3.2.2. Market Estimation and Forecast to 2030
5.3.3. Biopharmaceutical and Biologics Analysis
5.3.3.1. Market Definition
5.3.3.2. Market Estimation and Forecast to 2030
5.3.4. Sterile Compounding
5.3.4.1. Market Definition
5.3.4.2. Market Estimation and Forecast to 2030
5.3.5. Pharmaceutical Method Development and Research
5.3.5.1. Market Definition
5.3.5.2. Market Estimation and Forecast to 2030
5.3.6. Pharmaceutical X-Ray Diffraction
5.3.6.1. Market Definition
5.3.6.2. Market Estimation and Forecast to 2030
5.3.7. Excipient Raw Materials and Container Testing
5.3.7.1. Market Definition
5.3.7.2. Market Estimation and Forecast to 2030
5.3.8. Material Sciences Testing
5.3.8.1. Market Definition
5.3.8.2. Market Estimation and Forecast to 2030
5.3.9. Disinfection Qualification
5.3.9.1. Market Definition
5.3.9.2. Market Estimation and Forecast to 2030
5.3.10. Trace Metal Services
5.3.10.1. Market Definition
5.3.10.2. Market Estimation and Forecast to 2030
5.3.11. Others
5.3.11.1. Market Definition
5.3.11.2. Market Estimation and Forecast to 2030
6. North America Market Estimate and Forecast
6.1. By Sourcing Type
6.2. By Service Type
6.3. By Industry Vertical
6.4. By Country
6.4.1. U.S. Market Estimate and Forecast
6.4.2. Canada Market Estimate and Forecast
6.4.3. Mexico Market Estimate and Forecast
7. Europe Market Estimate and Forecast
7.1. By Sourcing Type
7.2. By Service Type
7.3. By Industry Vertical
7.4. By Country
7.4.1. Germany Market Estimate and Forecast
7.4.2. France Market Estimate and Forecast
7.4.3. U.K. Market Estimate and Forecast
7.4.4. Italy Market Estimate and Forecast
7.4.5. Spain Market Estimate and Forecast
7.4.6. Rest of Europe Market Estimate and Forecast
8. Asia-Pacific Market Estimate and Forecast
8.1. By Sourcing Type
8.2. By Service Type
8.3. By Industry Vertical
8.4. By Country
8.4.1. China Market Estimate and Forecast
8.4.2. Japan Market Estimate and Forecast
8.4.3. India Market Estimate and Forecast
8.4.4. South Korea Market Estimate and Forecast
8.4.5. Singapore Market Estimate and Forecast
8.4.6. Rest of Asia-Pacific Market Estimate and Forecast
9. Rest of the World (RoW) Market Estimate and Forecast
9.1. By Sourcing Type
9.2. By Service Type
9.3. By Industry Vertical
9.4. By Country
9.4.1. Brazil Market Estimate and Forecast
9.4.2. Saudi Arabia Market Estimate and Forecast
9.4.3. South Africa Market Estimate and Forecast
9.4.4. Other Countries Market Estimate and Forecast
10. Company Profiles
10.1. Intertek Group plc
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
10.2. Bureau Veritas
10.2.1. Snapshot
10.2.2. Overview
10.2.3. Offerings
10.2.4. Financial Insight
10.2.5. Recent Developments
10.3. UL LLC
10.3.1. Snapshot
10.3.2. Overview
10.3.3. Offerings
10.3.4. Financial Insight
10.3.5. Recent Developments
10.4. SGS SA
10.4.1. Snapshot
10.4.2. Overview
10.4.3. Offerings
10.4.4. Financial Insight
10.4.5. Recent Developments
10.5. Eurofins Scientific
10.5.1. Snapshot
10.5.2. Overview
10.5.3. Offerings
10.5.4. Financial Insight
10.5.5. Recent Developments
10.6. The British Standards Institution
10.6.1. Snapshot
10.6.2. Overview
10.6.3. Offerings
10.6.4. Financial Insight
10.6.5. Recent Developments
10.7. ALS Limited
10.7.1. Snapshot
10.7.2. Overview
10.7.3. Offerings
10.7.4. Financial Insight
10.7.5. Recent Developments
10.8. DEKRA SE
10.8.1. Snapshot
10.8.2. Overview
10.8.3. Offerings
10.8.4. Financial Insight
10.8.5. Recent Developments
10.9. Applus+
10.9.1. Snapshot
10.9.2. Overview
10.9.3. Offerings
10.9.4. Financial Insight
10.9.5. Recent Developments
10.10. TUV SUD
10.10.1. Snapshot
10.10.2. Overview
10.10.3. Offerings
10.10.4. Financial Insight
10.10.5. Recent Developments
11. Appendix
11.1. Exchange Rates
11.2. Abbreviations
Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.
List of Tables
Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2018 - 2023 (USD Billion)
Table 5 Global TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2025 - 2030 (USD Billion)
Table 6 Global TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2018 - 2023 (USD Billion)
Table 7 Global TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2025 - 2030 (USD Billion)
Table 8 Global TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2018 - 2023 (USD Billion)
Table 9 Global TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2025 - 2030 (USD Billion)
Table 10 Global TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2018 - 2023 (USD Billion)
Table 11 Global TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2025 - 2030 (USD Billion)
Table 12 North America TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2018 - 2023 (USD Billion)
Table 13 North America TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2025 - 2030 (USD Billion)
Table 14 North America TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2018 - 2023 (USD Billion)
Table 15 North America TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2025 - 2030 (USD Billion)
Table 16 North America TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2018 - 2023 (USD Billion)
Table 17 North America TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2025 - 2030 (USD Billion)
Table 18 North America TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2018 - 2023 (USD Billion)
Table 19 North America TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2025 - 2030 (USD Billion)
Table 20 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2018 - 2023 (USD Billion)
Table 21 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2025 - 2030 (USD Billion)
Table 22 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2018 - 2023 (USD Billion)
Table 23 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2025 - 2030 (USD Billion)
Table 24 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2018 - 2023 (USD Billion)
Table 25 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2025 - 2030 (USD Billion)
Table 26 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2018 - 2023 (USD Billion)
Table 27 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2025 - 2030 (USD Billion)
Table 28 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2018 - 2023 (USD Billion)
Table 29 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2025 - 2030 (USD Billion)
Table 30 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2018 - 2023 (USD Billion)
Table 31 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2025 - 2030 (USD Billion)
Table 32 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2018 - 2023 (USD Billion)
Table 33 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2025 - 2030 (USD Billion)
Table 34 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2018 - 2023 (USD Billion)
Table 35 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2025 - 2030 (USD Billion)
Table 36 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2018 - 2023 (USD Billion)
Table 37 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2025 - 2030 (USD Billion)
Table 38 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2018 - 2023 (USD Billion)
Table 39 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2025 - 2030 (USD Billion)
Table 40 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2018 - 2023 (USD Billion)
Table 41 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2025 - 2030 (USD Billion)
Table 42 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2018 - 2023 (USD Billion)
Table 43 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2025 - 2030 (USD Billion)
Table 44 Snapshot – Intertek Group plc
Table 45 Snapshot – Bureau Veritas
Table 46 Snapshot – UL LLC
Table 47 Snapshot – SGS SA
Table 48 Snapshot – Eurofins Scientific
Table 49 Snapshot – The British Standards Institution
Table 50 Snapshot – ALS Limited
Table 51 Snapshot – DEKRA SE
Table 52 Snapshot – Applus+
Table 53 Snapshot – TUV SUD
List of Figures
Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Sources for Different Parameters
Figure 4 Methodology
Figure 5 Data Pharmaceuticals & Biotech & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global TIC Market for Pharmaceuticals & Biotech Industry - Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global TIC Market for Pharmaceuticals & Biotech Industry Highlight
Figure 12 Global TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2018 - 2030 (USD Billion)
Figure 13 Global TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2018 - 2030 (USD Billion)
Figure 14 Global TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2018 - 2030 (USD Billion)
Figure 15 Global TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2018 - 2030 (USD Billion)
Figure 16 North America TIC Market for Pharmaceuticals & Biotech Industry Highlight
Figure 17 North America TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2018 - 2030 (USD Billion)
Figure 18 North America TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2018 - 2030 (USD Billion)
Figure 19 North America TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2018 - 2030 (USD Billion)
Figure 20 North America TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2018 - 2030 (USD Billion)
Figure 21 Europe TIC Market for Pharmaceuticals & Biotech Industry Highlight
Figure 22 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2018 - 2030 (USD Billion)
Figure 23 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2018 - 2030 (USD Billion)
Figure 24 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2018 - 2030 (USD Billion)
Figure 25 Europe TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2018 - 2030 (USD Billion)
Figure 26 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Highlight
Figure 27 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2018 - 2030 (USD Billion)
Figure 28 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2018 - 2030 (USD Billion)
Figure 29 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2018 - 2030 (USD Billion)
Figure 30 Asia-Pacific TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2018 - 2030 (USD Billion)
Figure 31 RoW TIC Market for Pharmaceuticals & Biotech Industry Highlight
Figure 32 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, By Sourcing Type, 2018 - 2030 (USD Billion)
Figure 33 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, By Service Type, 2018 - 2030 (USD Billion)
Figure 34 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, By Industry Vertical, 2018 - 2030 (USD Billion)
Figure 35 RoW TIC Market for Pharmaceuticals & Biotech Industry Size, by Region, 2018 - 2030 (USD Billion)
Global TIC Market for Pharmaceuticals & Biotech Industry- Market Coverage
Sourcing Type Insight and Forecast 2025-2030
Service Type Insight and Forecast 2025-2030
Industry Vertical Insight and Forecast 2025-2030
Geographical Segmentation
TIC Market for Pharmaceuticals & Biotech Industry by Region
North America
Europe
Asia-Pacific (APAC)
Rest of the World (RoW)
Vynz Research know in your business needs, you required specific answers pertaining to the market, Hence, our experts and analyst can provide you the customized research support on your specific needs.
After the purchase of current report, you can claim certain degree of free customization within the scope of the research.
Please let us know, how we can serve you better with your specific requirements to your research needs. Vynz research promises for quick reversal for your current business requirements.
Purchase Options
Latest Report
Research Methodology
Connect With Our Sales Team
TIC Market for Pharmaceuticals & Biotech Industry